These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 21154153)
1. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures. Rogers WK; McDowell TS IDrugs; 2010 Dec; 13(12):929-37. PubMed ID: 21154153 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology. Saari TI; Uusi-Oukari M; Ahonen J; Olkkola KT Pharmacol Rev; 2011 Mar; 63(1):243-67. PubMed ID: 21245208 [TBL] [Abstract][Full Text] [Related]
3. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555 [TBL] [Abstract][Full Text] [Related]
4. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270 [TBL] [Abstract][Full Text] [Related]
13. Remimazolam: An Updated Review of a New Sedative and Anaesthetic. Hu Q; Liu X; Wen C; Li D; Lei X Drug Des Devel Ther; 2022; 16():3957-3974. PubMed ID: 36411859 [TBL] [Abstract][Full Text] [Related]
14. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Rex DK; Bhandari R; Desta T; DeMicco MP; Schaeffer C; Etzkorn K; Barish CF; Pruitt R; Cash BD; Quirk D; Tiongco F; Sullivan S; Bernstein D Gastrointest Endosc; 2018 Sep; 88(3):427-437.e6. PubMed ID: 29723512 [TBL] [Abstract][Full Text] [Related]
15. Hypnotic and sedative drugs--anything new on the horizon? Gin T Curr Opin Anaesthesiol; 2013 Aug; 26(4):409-13. PubMed ID: 23820101 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology of sedation agents and reversal agents. Fassoulaki A; Theodoraki K; Melemeni A Digestion; 2010; 82(2):80-3. PubMed ID: 20407249 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of intranasal remimazolam-a randomized controlled clinical trial. Pesic M; Schippers F; Saunders R; Webster L; Donsbach M; Stoehr T Eur J Clin Pharmacol; 2020 Nov; 76(11):1505-1516. PubMed ID: 32886178 [TBL] [Abstract][Full Text] [Related]
19. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys. Kops MS; Pesic M; Petersen KU; Schmalix WA; Stöhr T Eur J Pharmacol; 2021 Jan; 890():173639. PubMed ID: 33065095 [TBL] [Abstract][Full Text] [Related]
20. Induction and maintenance of procedural sedation in adults: focus on remimazolam injection. Chen W; Chen S; Huang Y Expert Rev Clin Pharmacol; 2021 Apr; 14(4):411-426. PubMed ID: 33686920 [No Abstract] [Full Text] [Related] [Next] [New Search]